SENSEX NIFTY

Glenmark Pharmaceuticals

Apr 20, 2017 at 15:20 | Source: CNBC-TV18
Rajat Bose of rajatkbose.com advises exiting Glenmark Pharma.
Apr 19, 2017 at 11:34 | Source: PTI
"Glenmark Pharmaceuticals Inc, USA has been granted tentative approval by the United States Food & Drug Administration (USFDA) for Dabigatran Etexilate Capsules, 75 mg, 110 mg and 150 mg," Glenmark Pharmaceuticals said in a BSE filing.
Apr 19, 2017 at 08:52 | Source: Moneycontrol.com
Glenmark Pharmaceuticals Inc., USA has been granted tentative approval by the USFDA for Dabigatran Etexilate Capsules, 75 mg, 110 mg and 150 mg, the generic version of Pradaxa Capsules, 75 mg, 110 mg and 150 mg of Boehringer Ingelheim Pharmaceuticals, Inc.
Apr 17, 2017 at 13:33 | Source: Moneycontrol.com
Net Sales are expected to increase by 14.5 percent Q-o-Q (up 27.2 percent Y-o-Y) to Rs 2902.7 crore, according to ICICI Securities. Glenmark to report net profit at 590 crore up 28.3% quarter-on-quarter.
Apr 10, 2017 at 12:50 | Source: PTI
The company has been granted final approval by the United States Food and Drug Administration (USFDA) for Fenofibrate Capsules USP, 67 mg, 134 mg and 200 mg, Glenmark Pharmaceuticals said in a statement.
Apr 10, 2017 at 11:25 | Source: Moneycontrol.com
The company's current portfolio consists of 114 products authorized for distribution in the US marketplace and approximately 64 ANDAs pending approval with the USFDA.
Apr 10, 2017 at 09:29 | Source: Moneycontrol.com
Glenmark Pharmaceuticals Inc., USA has been granted final approval by the United States Food & Drug Administration (USFDA) for Fenofibrate Capsules USP, 67 mg, 134 mg and 200 mg, the generic version of Tricor Micronized Capsules, 67 mg, 134mg, and 200 mg of AbbVie, Inc.
Apr 10, 2017 at 09:26 | Source: CNBC-TV18
Sudarshan Sukhani of s2analytics.com is of the view that one can short Glenmark Pharma and Just Dial while can buy Dabur India, Apollo Tyres and Tata Chemicals.
Apr 06, 2017 at 11:52 | Source: CNBC-TV18
Sudarshan Sukhani of s2analytics.com is of the view that one can sell Glenmark Pharma while buy BEML and Bharat Forge.
Mar 31, 2017 at 13:38 | Source: Moneycontrol.com
Glenmark Pharmaceuticals receives tentative ANDA approval for Milnacipran Hydrochloride Tablets.
Messages on Glenmark Pharmaceuticals »

kingstocks2
3

New Member

8 Followers

Glenmark  

glenmark pharmaceuticals inc, usa has been granted tentative approval by the united states food & drug administration (usfda) for dabigatran etexilate capsules, 75 mg, 110 mg and 150 mg, glenmark pharmaceuticals said in a bse filing.

11.57 AM Apr 19th

kingstocks2
3

New Member

8 Followers

Glenmark  

glenmark pharmaceuticals has received tentative nod from the us health regulator for anti—coagulant medication dabigatran etexilate capsules.

11.57 AM Apr 19th

BSE/NSE Announcer

Platinum Member

22695 Followers

Glenmark  

Glenmark Pharmaceuticals Ltd has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2017. For more details, kindly Click here

6.12 PM Apr 11th

porfavor

New Member

4 Followers

Sun Pharma  

-licensing deals are Sun Pharmaceutical Industries Ltd, Lupin Ltd, Dr. Reddy s Laboratories Ltd and Glenmark Pharmaceuticals Ltd.

1.36 PM Apr 11th

selfieflash

New Member

8 Followers

Glenmark  

the company has been granted final approval by the united states food and drug administration (usfda) for fenofibrate capsules usp, 67 mg, 134 mg and 200 mg, glenmark pharmaceuticals said in a statement.

1.50 PM Apr 10th

k.v.renga

Platinum Member

1527 Followers

Glenmark  

NEW DELHI, MARCH 31: Glenmark Pharmaceuticals has received tentative approval from the USFDA for Milnacipran Hydrochloride tablets. Glenmark Pharmaceuticals Inc, USA, has been granted tentative approval by the United States Food and Drug Administration (USFDA) for Milnacipran Hydrochloride

7.34 PM Mar 31st

BSE/NSE Announcer

Platinum Member

22695 Followers

Glenmark  

Glenmark Pharmaceuticals receives tentative ANDA approval for Milnacipran Hydrochloride Tablets.

1.38 PM Mar 31st

BSE/NSE Announcer

Platinum Member

22695 Followers

Glenmark  

Glenmark Pharmaceuticals announced positive results for GSP 301, an investigational fixed-dose combination of mometasone furoate (25 mcg) and olopatadine hydrochloride (665 mcg) administered twice daily as a nasal spray being studied for the treatment of seasonal allergic rhinitis.

10.01 AM Mar 30th

niftytrend0
0

Platinum Member

131 Followers

Glenmark Pharma  

Sell glenmark pharmaceutical stock it may deep to 860 -840 level...

12.10 PM Mar 27th

niftytrend0
0

Platinum Member

131 Followers

Glenmark Pharma  

sell glenmark Pharmaceutical stock it may deep to 860 -840 level

12.09 PM Mar 27th

News across the web »
Follow us on
Available On